MY148491A
(en )
2013-04-30
FUSED BICYCLIC mTOR INHIBITORS
TW200738725A
(en )
2007-10-16
Unsaturated mTOR inhibitors
NO2017019I2
(en )
2017-05-04
Enzalutamide or a pharmaceutically acceptable salt thereof
IL251185A0
(en )
2017-05-29
Mek inhibitors and method of their use
TW200740776A
(en )
2007-11-01
N-phenylbenzotriazolyl c-kit inhibitors
GEP20105024B
(en )
2010-06-25
Fused heterocyclic compound
UA84712C2
(en )
2008-11-25
N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
TW200519111A
(en )
2005-06-16
N3-substituted imidazopyridine C-KIT inhibitors
MY146111A
(en )
2012-06-29
Acylaminopyrazoles as fgfr inhibitors
AP2378A
(en )
2012-03-08
Sulfonamide derivatives for the treatment of diseases.
EA200801428A1
(en )
2008-10-30
PYRIDIAZINONE DERIVATIVES FOR THE TREATMENT OF TUMORS
AP2359A
(en )
2012-01-30
Sulfonamide derivatives for the treatment of diseases.
MY148688A
(en )
2013-05-31
2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
HK1121440A1
(en )
2009-04-24
Biphenyl derivatives and their use in treating hepatitis c
ATE432281T1
(en )
2009-06-15
PYRROLOTRIAZINE KINASE INHIBITORS
NZ593440A
(en )
2013-02-22
Aminopyrazole compounds useful for inhibiting chk1
WO2007120333A3
(en )
2008-01-10
Tetracyclic kinase inhibitors
TW200639156A
(en )
2006-11-16
New compounds
UA96304C2
(en )
2011-10-25
2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
UA96969C2
(en )
2011-12-26
Acylaminopyrazoles as fgfr inhibitors
IL177455A0
(en )
2006-12-10
Pyrazoline derivatives useful for the treatment of cancer
ZA200801332B
(en )
2009-10-28
Pentacyclic kinase inhibitors
TW200626588A
(en )
2006-08-01
(Arylamidoaryl)cyanoguanidine compounds
GB0515025D0
(en )
2005-08-31
Organic compounds
UA94070C2
(en )
2011-04-11
FUSED BICYCLIC mTOR INHIBITORS